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Abstract
The HAVCR2 gene encodes TIM-3, an immunoglobulin superfamily member expressed by exhausted CD8+ T cells during
chronic viral infection. We investigated whether genetic variation at HAVCR2 modulates the susceptibility to HIV-1
acquisition; specifically we focused on a 39 UTR variant (rs4704846, A/G) that represents a natural selection target. We
genotyped rs4704846 in three independent cohorts of HIV-1 exposed seronegative (HESN) individuals with different
geographic origin (Italy and Spain) and distinct route of exposure to HIV-1 (sexual and injection drug use). Matched HIV-1
positive subjects and healthy controls were also analyzed. In all case-control cohorts the minor G allele at rs4704846 was
more common in HIV-1 infected individuals than in HESN, with healthy controls showing intermediate frequency. Results
from the three association analyses were combined through a random effect meta-analysis, which revealed no
heterogeneity among samples (Cochrane’s Q, p value = 0.89, I2 = 0) and yielded a p value of 6.861024. The minor G allele
at rs4704846 was found to increase HAVCR2 expression after in vitro HIV-1 infection. Thus, a positively selected
polymorphism in the 39 UTR, which modulates HAVCR2 expression, is associated with the susceptibility to HIV-1 infection.
These data warrant further investigation into the role of TIM-3 in the prevention and treatment of HIV-1/AIDS.
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Introduction
TIM-3 (T cell immunoglobulin and mucin domain-containing
molecule 3) is an immunoglobulin superfamily member encoded in
humans by the HAVCR2 (hepatitis A virus cellular receptor 2)
gene. Initially identified as a marker of IFN-c-producing CD4+
Th1 and CD8+ Tc1 cells [1], TIM-3 was more recently shown to
be expressed by several other immune cell types including NK/
NTK, macrophages/monocytes, and dendritic cells [2]. The
protein product of HAVCR2 can bind both galectin 9 (Gal-9) and
phosphatidylserine [2]. Engagement of TIM-3 by Gal-9 on T cells
induces cell death and promotes peripheral tolerance [2]. Thus,
TIM-3 plays an important role in the negative regulation of T-cell
mediated responses, and abrogation of its signaling increases the
secretion of IFN-c by activated human T cells [3]. Recent
evidences have indicated that expression of TIM-3 marks a
population of exhausted CD8+ T cells during chronic viral
infection [2]. Specifically, in progressive HIV-1 infection TIM-3
defines an abundant population of CD8+ T cells and its expression
correlates positively with viral load and inversely with CD4+ T cell
counts [4]. The loss of proliferative activity of HIV-specific TIM-
3-expressing CD8+ cells is partially mediated by the interaction
with Gal-9 on Treg cells and is modulated by HLA-B allelic status
[5]. Despite these observations, the role of TIM-3 in HIV-1
acquisition has never been analyzed.
We have reported that a variant located in the 39UTR of
HAVCR2 (rs4704846) has been a target of natural selection in
human populations and suggested that the selective pressure is
accounted for by infectious agents [6]. In line with this view, a
SNP (rs3087616) located 62 bp apart and in full linkage
disequilibrium with rs4704846 (r2 = 1 in Europeans) has recently
been shown to act as an expression QTL (eQTL) in CD14+
monocytes [7]. Given the central role of TIM-3 in viral infection
[2], and because evolutionary and eQTL analyses point to
rs4704846 (or a closely linked variant) as a functional polymor-
phism, we investigated whether this SNP modulates the suscep-
tibility to HIV-1 infection.
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Materials and Methods
Ethics statement
The study was designed and performed according to the
Helsinki declaration and was approved by the Ethics Committees
of following Institutions: University of Jaen, Valme Hospital
(Seville), Reina Sofia Universitary Hospital (Cordoba), and S.
Maria Annunziata Hospital (Florence). All patients and healthy
blood donors provided written informed consent to participate in
this study.
Subject cohorts
Ninety-three Italian HESN that had been exposed to the virus
through unprotected sexual intercourse (SexExp-HESN) and 87
HIV-1-infected subjects were recruited at the S. M. Annunziata
Hospital in Florence, Italy; all of them were Italian of European
origin. Inclusion criteria for HESN were a history of multiple
unprotected sexual episodes for more than 4 years at the time of
the enrolment, with at least 3 episodes of at-risk intercourse within
4 months prior to study entry, and an average of 30 (range, 18 to
.100) reported unprotected sexual contacts per year [8]. All
individuals (SexExp-HESN and HIV-1 infected) had been
longitudinally followed for .4 years before the study by the
Department of Obstetrics and Gynecology of the S. M.
Annunziata Hospital. This allowed us to exclude from the study
HESN and HIV-1 infected subjects in whom sexually transmitted
diseases or any other pathology were reported during that time
period. The range of CD4 counts in HIV-1 infected patients were
36–850 cells/ml, and viral loads were .50–750000 copies/ml. All
of the patients were receiving highly active antiretroviral therapy
(HAART) at the time of the study.
Thirty-eight Spanish HESN that had been exposed to the virus
through unprotected sexual intercourse (SexExp-HESN) were
recruited as well. These subjects are female partners of HIV-1
infected patients that were treatment-naive and viremic. In this
case, mean number of unprotected sexual intercourse per year was
110 and the mean number of years of unprotected sex was 5
(range 3–17 years). Healthy controls (HC, n = 77) were anony-
mous blood donors from the City of Jaen Hospital in Jaen, Spain.
Finally, we recruited 190 males exposed to HIV-1 infection by
injection drug use (IDU) and enrolled in prospective cohort studies
in Spain (Valme Hospital, Sevilla) who had shared needles for .3
months. Concurrent markers of hepatitis C virus (HCV) infection,
the most chronic viral infection transmitted by sharing needles,
were present in 100% of IDU subjects. These values are
significantly higher than the reported HCV prevalence of 1%–
2% for the general population in Spain. Ninety-three of these
subjects were HIV-1 negative (IDU-HESN), 97 were HIV-1
positive (IDU-CTR). The mean of CD4 cells in HIV-1 infected
patients was 6486408 mm3, and viral loads were undetectable in
81% of the patients. 87% of these patients were receiving HAART
at the time of the study.
All subjects were Spanish of European origin. The main
epidemiological characteristics of the populations studied are
detailed in Table 1.
Genotyping and statistical analysis
Genomic DNA was used as template for PCR amplification
using TaqMan probes specifically designed to perform a SNP
genotyping assay for rs4704846 (G/A) and using the allelic
discrimination real-time PCR method. Assays were performed in
10 ml reactions, using TaqMan Genotyping Master Mix on 96-
well plates using a ABI 7000 instrument (Applied Biosystems
Foster City, CA, USA). The variant complied to Hardy-Weinberg
equilibrium in all samples. Genetic association analyses were
performed by logistic regression using an additive model, and
results from the three cohorts were combined using a random-
effect meta-analysis; all analyses were performed using PLINK [9].
Linkage disequilibrium analyses were performed using Haploview
(v. 4.1) [10] and blocks were identified through the confidence
interval algorithm implemented in the software [11].
PBMC isolation, HIV-1 infection, and transcript
quantification
Whole blood was collected from 40 healthy volunteers by
venipuncture in Vacutainer tubes containing EDTA (Becton
Dickinson), and PBMCs were separated on lymphocyte separation
medium (Organon Teknica, Malvern, PA). PBMCs (106106 cells/
ml) were cultured for 2 days at 37uC and 5% CO2 in RPMI 1640
containing FBS (20%), PHA (7.5 ı`g/ml), and IL-2 (15 ng/ml).
After viability assessment, 2.56106 cells were resuspended in
medium containing or not containing 1 ng HIV-1Ba-L/16106
PBMC and incubated for 3 h at 37uC. Cells were then washed and
resuspended in 3 ml complete medium with IL-2 (15 ng/ml). Cells
were plated in 24-well tissue culture plates and incubated at 37uC
and 5% CO2. After 3 days, 2.56105 PBMCs were collected for
gene expression analysis. RNA was extracted from cultured
PBMCs and from HIV-1-infected PBMCs by using the acid
guanidium thiocyanate–phenol–chloroform method. The RNA
was treated with RNase-free DNase (New England Biolabs,
Ipswich, MA). One microgram of RNA was reverse transcribed
into first-strand cDNA in a 20-ı`l final volume containing 1 ı`M
random hexanucleotide primers, 1 ı`M oligonucleotide, and 200 U
Moloney murine leukemia virus reverse transcriptase (Promega,
Madison, WI). cDNA quantification for HAVCR2 and GAPDH
was performed by real-time PCR (DNA Engine Opticon 2; MJ
Research, Ramsey, NJ). Reactions were performed using a SYBR
Green PCR mix (5 prime, Gaithersburg, MD). Results were
expressed as A¨A¨Ct and presented as ratios between the target gene
and the GAPDH housekeeping mRNA.
Results
As mentioned above, rs4704846 is located in the 39UTR of
HAVCR2. The ancestral minor G allele displays a frequency of
0.39, 0.20, and 0.01 in Africans (Yoruba), Europeans and Japanese
plus Chinese, respectively, as assessed by the 1000 Genomes
Project data [12]. Analysis of linkage disequilibrium (LD) in
Europeans along HAVCR2 indicated that rs4704846 lies within
an LD block that also includes rs3087616, an eQTL in naive
CD14+ monocytes. The variant is also in full LD with several
SNPs that were described as eQTLs in lymphoblastoid cell lines
[13,14] (Fig. 1). The 39UTR of HAVCR2 is moderately conserved
in mammals, as assessed through the GERP (Genomic Evolution-
ary Rate Profiling) score [15] (Fig. 1); prediction of regulatory
motifs using rSNPBase [16] indicated that rs4704846 maps to
regions showing H3K27ac histone marks (usually associated with
active regulatory elements) in CD14+ monocytes and several
microRNA binding sites are observed across the entire 39 UTR
(microRNa.org, http://www.microrna.org/microrna/home.do).
The presence of regulatory motifs was further analyzed using
HaploReg [17]: rs4704846 was found to affect a Smad4 binding
site (Fig. 1). Smad4 is a mediator of TGF-beta signaling and its
expression after SIV infection differs in rhesus macaque and
African green monkeys, which are differentially susceptible to SIV-
mediated immunopathology [18].
To explore the role of rs4704846 in HIV-1 acquisition, we
genotyped this variant in a well characterized cohort of 93
HAVCR2 and Susceptibility to HIV-1 Infection
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Table 1. Characteristic of the study cohorts.
HESN
HIV-1
infected HESN
HC (HIV-1
negative) HESN HIV-1 infected
Cohort Origin Italy Spain Spain
Exposure Heterosexual Heterosexual IDU
Total Number 93 87 38 77 93 97
Age (mean± SDa) 4968.6 4765.9 4066.9 3968.9 3267.6 3468.6
Gender (male/female) 30/63 31/56 0/38 0/77 93/0 97/0
Time of injection drug use (months) - - 52623.2
Mean number of unprotected
sexual intercourse per year
30 110 -
aSD: standard deviation.
doi:10.1371/journal.pone.0106442.t001
Figure 1. LD analysis and functional annotation. The HAVCR2 gene region is shown within the UCSC Genome Browser view. Variants that have
been described as eQTLs in monocytes and lymphoblastoid cell lines are in green and blue, respectively. The variant we analyzed is in red. The
location of predicted functional elements and microRNA binding sites is also shown. LD analysis is reported in the bottom panel; data refer to
Europeans and derive from the 1000 Genomes Projects Phase I data for Europeans (CEU) [12]. r2 was calculated with the Haploview software and
blocks were identified through the implemented confidence interval algorithm (see methods).
doi:10.1371/journal.pone.0106442.g001
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heterosexual Italian subjects who have a history of unprotected sex
with their seropositive partners (sex-exposed HESN, SexExp-
HESN). The allele frequency of rs4704846 in these subjects was
compared to that observed in a sample of 87 Italian HIV-1
positive individuals. A significant difference was observed, with the
minor G allele being much more common in HIV-1 infected (0.25)
compared to SexExp-HESN (0.14) (Table 2). The frequency of the
G allele in Italians is 0.21, as determined by the 1000 Genomes
Phase I Project. We genotyped 300 Italian healthy subjects and
obtained a similar frequency of 0.20, which is therefore
intermediate between HIV-1 infected and SexExp-HESN. A very
similar result was obtained in a second and smaller cohort of
SexExp-HESN (n = 38) from Spain: in these subjects the frequency
of the G allele was 0.12, much lower than in a sample of 77
Spanish healthy controls (HC, frequency = 0.20); due to the small
sample size the association p value did not reach statistical
significance (Table 2). Finally, to replicate these results, a third
HESN population with a different route of exposure to HIV-1 was
analyzed. In particular, we recruited 190 Spanish injection drug
users (IDU): all of them were HCV-positive, but, whereas 97
subjects were HIV-1 infected (IDU-HIV-1 infected) as well, the
remaining 93 individuals tested HIV-1 negative despite multiple
exposures through needle sharing (IDU-HESN). Again, the G
allele was more common in IDU-HIV-1 infected compared to
IDU-HESN with a borderline significance of 0.064.
Results from the three association analyses were combined
through a random effect meta-analysis, which revealed no
heterogeneity among samples (Cochrane’s Q p value = 0.89,
I2 = 0) and yielded a p value of 6.8 61024 (Table 2). Overall,
these results strongly suggest that the minor G allele of rs4704846
is associated with increased risk of HIV-1 acquisition.
To assess whether the modulatory effect of rs4704846 on HIV-1
susceptibility is exerted through changes in HAVCR2 expression,
we performed an in vitro infection assay. Specifically, PBMCs
from 40 healthy subjects (27 AA, 13 AG) were infected with HIV-1
and HAVCR2 transcript abundance was quantified by real-time
PCR after 3 days. As shown in figure 2, significantly higher
HAVCR2 expression was observed following in vitro HIV-1
infection in AG heterozygotes compared to AA homozygotes
(Student’s t-test, p = 0.028) (Fig. 2); the same trend was observed in
uninfected PBMCs, although the difference was less marked and
did not reach statistical significance (Fig. 2).
Discussion
We analyzed three independent HESN cohorts and in all cases
we observed the same trend: HIV-1 infected subjects are more
likely to carry the G allele than HESN, with healthy controls
showing intermediate frequency. Therefore, although statistical
analysis was fully significant for the Italian cohort only, the meta-
analysis we performed revealed no heterogeneity in the effect of
rs4704846 among the three samples and yielded a highly
significant association result. Indeed, the small sample size of
HESN cohorts, which is conceivable given the characteristics of
these subjects, make replication across populations and meta-
analysis a powerful approach to discover susceptibility variants for
HIV-1 infection. We should add that the single case-control
samples used either HIV-1 infected or HC subjects as a
comparison to HESN; nonetheless, we believe meta-analysis to
be appropriate as HIV-1 infection susceptibility is a common
condition to most humans [19,20].
The interaction between TIM-3 and Gal-9 acts to limit the
extent of CD8+ T cell immunity to HSV infection [21] and over-
expression of TIM-3 on CD4+ and CD8+ T cells correlates with
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diseases progression in chronic hepatitis B infection [22]. Likewise,
the chronic persistence of HIV-1 is associated with the increased
expression of TIM-3 on CD4+ and virus-specific CD8+ T cells [4].
Results herein fit within this scenario by showing that the
expression level of HAVCR2 following infection is at least partially
determined by a polymorphism that also affects susceptibility to
HIV-1. Although protein and RNA levels do not correlate
perfectly in humans[23], it is conceivable that allelic status at
rs4704846 also affects TIM-3 abundance in PBMCs.
Natural selection targets variants with a phenotypic effect and
acts in response to specific selective pressures. The major allele of
rs4704846, which associates with lower susceptibility to HIV-1
acquisition, has been driven to high frequency in human
populations by natural selection [6]. Because its appearance as a
human pathogen is recent, HIV-1 cannot be regarded as the
underlying selective pressure. Nonetheless, as mentioned above,
TIM-3 dysregulation has been associated with chronic and acute
infections with other viral species [4,22,24], suggesting that extant
or extinct pathogens drove the frequency increase of the protective
allele. The location of rs4704846 in the 39 UTR and its full
linkage-disequilibrium with eQTLs in monocytes and lympho-
blastoid cell lines are in agreement with the effect we observed on
HAVCR2 expression; nonetheless, the underlying molecular
mechanism(s) (miRNA-mediated regulation, transcription factor
binding site alteration or other) remains to be determined.
Although replication in additional independent samples will be
necessary, data herein warrant further investigation into the role of
HAVCR2 in the prevention and treatment of HIV-1/AIDS.
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